Add BrightSurf on Google Email

Revealing the secrets of cell competition

Research found that cells with defective mitochondria and sequence changes in their genome are 'loser' cells in mouse embryos, suggesting that mitochondrial dysfunction is a common characteristic of competing cells. The study suggests that mitochondrial activity may be a key determinant of cellular fitness in various biological contexts.

Quantum physics helps destroy cancer cells

Researchers at Kyoto University have discovered a way to enhance radiation therapy using iodine nanoparticles, which trigger cancer cell death when exposed to X-rays. The study reveals that the optimal energy level for X-ray irradiation is 33.2 keV, causing double-strand breaks in DNA and leading to programmed cell death.

SourceKyoto University·JournalScientific Reports·DateJul 14, 2021

Anti-cancer immunotherapy drug with reduced side effects and increased therapeutic effects

Researchers have developed an anti-cancer prodrug that targets cancer cells while minimizing toxicity to normal cells. This innovation improves the effectiveness of immunotherapy by boosting patient immunity. The drug exhibits anticancer effects when activated in cancer cells, inducing an active anticancer immune response.

A frozen leap forward

Scientists at UC Santa Barbara and Regenerative Patch Technologies have developed a new cryopreservation method for stem cell-based therapy for age-related macular degeneration. The method allows for long-term storage and distribution of the implant, extending shelf life and increasing accessibility to patients.

SourceUniversity of California - Santa Barbara·JournalScientific Reports·DateJun 14, 2021

Pinpointing how cancer cells turn aggressive

A team of scientists has developed a new method for tracing the lineage and gene expression patterns of metastatic cancer cells at the single-cell level. The researchers found that a spectrum of aggression exists in cancer cells, with some cells more likely to remain in place and others more likely to spread to other tissues.

SourceUniversity of Pennsylvania·JournalCancer Cell·DateJun 10, 2021

Collaboration controls killers

Scientists at St. Jude Children's Research Hospital studied enhancers that regulate Foxp3 gene expression to control effector and killer T cells. They found that these enhancers work together to curb the immune cells' activity, ensuring they only attack cancer cells.

SourceSt. Jude Children's Research Hospital·JournalJournal of Experimental Medicine·DateJun 4, 2021

Challenging the standard model of cancer

Researchers propose a new atavistic model of cancer, suggesting that ancient genes and reversions to ancestral forms are responsible for cancer's ability to survive and proliferate. The Serial Atavism Model challenges the conventional standard model of cancer, offering a novel perspective on the disease.

SourceArizona State University·JournalBioEssays·DateMay 20, 2021

Protected by nanobrushes

Researchers developed nanosized cargo packages that can deliver water-soluble proteins into cancer cells while keeping them intact. The 'nanobrushes' use polymer strands with antibodies on the outside and protected proteins within.

SourceWiley·JournalAngewandte Chemie International Edition·DateMay 6, 2021